Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01711541
Title Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

head and neck squamous cell carcinoma

Therapies

Carboplatin + Etoposide + Veliparib

Cisplatin + Fluorouracil + Hydroxyurea

Carboplatin + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.